SNOA (Sonoma Pharmaceuticals) צמיחת הכנסות מרבעון לרבעון

Optimized supply chains in the US and Europe guarantee the uninterrupted delivery of medications. Sonoma Pharmaceuticals management is expanding the distribution of over-the-counter drugs, effectively reducing costs. The quarterly revenue growth rate confirms the successful implementation of chlorinating solutions in clinics, creating a stable B2B stream, while the 27.70 mark serves as the current indicator of this trend.
פילוחים אנליטיים של חברת Sonoma Pharmaceuticals (SNOA)

A comparative asset analysis requires evaluating sales dynamics by calculating the percentage deviation of current quarterly revenue from the figures of the same period last year. For Sonoma Pharmaceuticals (SNOA), this indicator reflects the effectiveness of licensing agreements with pharmacy chains rather than expansion through acquisitions, allowing the quarterly revenue growth chart to objectively demonstrate the pace of the business's organic development.